Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-04

Clinical Trial Update: Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the effect of sitagliptin on glucagon secretion, insulin secretion, and insulin resistance in Chinese adults with type 2 diabetes. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sitagliptin (sitagliptin)

Snippet

Sponsor: Guangwei Li | Conditions: Insulin Secretion, Insulin Resistance | Phase 4 | Status: COMPLETED | Results posted: 2017-04-04